Epigenetic differences in NCOA2: a novel biomarker that predicts prognosis in clear cell renal cell carcinoma.

Zhixian Chen,Liang Wang,Jian Shi,Wen Xiao,Changfei Yuan,Xiangui Meng,Hailong Ruan,Zhiyong Xiong,Xiaoping Zhang

American journal of translational research（2023）

引用 0|浏览8

暂无评分

摘要

NCOA2 has great potential to serve as a novel biomarker that can predict prognosis in ccRCC and may become a new therapeutic target in patients with late-stage ccRCC.

查看译文

关键词

NCOA2, biomarker, prognosis, renal cell carcinoma, DNA methylation, immune infiltration

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要